Skip to main content
TKNO
NASDAQ Life Sciences

Alpha Teknova Reports Significant Reduction in Net Loss and Strong Gross Profit Growth for FY2025

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.38
Mkt Cap
$127.399M
52W Low
$1.91
52W High
$7.48
52W Position info
25% above low
Off High info
68% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

TKNO sits 25% above its 52-week low of $1.91 on light trading volume (0.4× avg).

Summary

Alpha Teknova reported a 35.5% reduction in net loss and an 85.9% increase in gross profit for fiscal year 2025, alongside 7.4% revenue growth and maintained compliance with debt covenants.


Key Events · Earnings and Guidance · TKNO

  • Net Loss Significantly Reduced

    The company's net loss improved by 35.5%, decreasing from $26.7 million in 2024 to $17.3 million in 2025.

  • Revenue Growth Achieved

    Total revenue increased by 7.4% to $40.5 million in 2025, up from $37.7 million in 2024.

  • Gross Profit Margin Substantially Improved

    Gross profit surged by 85.9% to $13.4 million in 2025, with the gross profit percentage rising from 19.2% to 33.2%, primarily due to manufacturing efficiency and higher revenue.

  • Maintained Debt Covenant Compliance

    Alpha Teknova was in compliance with all financial covenants under its Second Amended and Restated Credit Agreement as of December 31, 2025.


Analysis · TKNO · Life Sciences

Alpha Teknova, Inc. has filed its annual 10-K report, detailing a substantial improvement in its financial performance for the fiscal year ended December 31, 2025. The company significantly reduced its net loss by 35.5% and achieved robust revenue growth of 7.4%. A notable highlight is the impressive 85.9% increase in gross profit, driven by higher revenue and manufacturing efficiency gains. This positive financial trend, following a preliminary announcement in a recent 8-K, indicates operational improvements and a stronger financial position. The company also maintains a $28.245 million credit facility and has a $225 million shelf registration statement in place, providing flexibility for future capital needs, and was in compliance with all debt covenants as of year-end 2025. While still operating at a net loss, the significant progress in reducing losses and improving margins suggests a positive trajectory for the company's financial health and operational efficiency.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TKNO was trading at $2.38 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $127.4M. The 52-week trading range was $1.91 to $7.48. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TKNO - Latest Insights

TKNO
Nov 04, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.37
Real-time Price: $7.63 info
Change: +$0.260 (+4%) info
Market Cap: $479.951M info
TKNO
Nov 04, 2026, 4:02 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $7.37
Real-time Price: $7.63 info
Change: +$0.260 (+4%) info
Market Cap: $479.951M info
TKNO
Oct 21, 2026, 4:41 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.65
Real-time Price: $7.63 info
Change: +$1.98 (+35%) info
Market Cap: $479.951M info
TKNO
Oct 21, 2026, 4:36 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $5.81
Real-time Price: $7.63 info
Change: +$1.82 (+31%) info
Market Cap: $479.951M info
TKNO
Oct 20, 2026, 10:30 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $5.70
Real-time Price: $7.63 info
Change: +$1.93 (+34%) info
Market Cap: $479.951M info